Product Information
TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.1159 per EA under NDC 53746061705. Its NADAC has been published 656 times since Mar 12, 2014.
FDA first approved this application on Dec 9, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
325; 37.5 mg/1; mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
53746061705
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; TRAMADOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090485FDA Approved
12/9/2009
TE Code
AB
On Market Since
12/17/2009
Pharmacological Classes
Price Statistics
The NADAC for TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB has been published 656 times since Mar 12, 2014, and over the history we have for it it has declined 47.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1159 per EA |
|---|---|
| All-time high | $0.2270 (May 13, 2015) |
| All-time low | $0.0806 (Nov 20, 2024) |
| 52-week high | $0.1159 |
| 52-week low | $0.1014 |
| Median price | $0.1287 |
| Average price | $0.1446 |
| Largest weekly change | -29.5% (Jan 18, 2017) |
| Weeks tracked | 656 |
| Tracking since | Mar 12, 2014 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tramadol Hydrochloride and Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.1159 per EA (NDC 53746061705), effective Sep 30, 2026.
How has the price of TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB changed over time?
Over the history we have for it, the NADAC for TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB has declined 47.4%. It has been tracked across 656 weekly CMS publications since Mar 12, 2014.
What are the highest and lowest recorded NADAC prices for TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB?
Since Mar 12, 2014, the NADAC for TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB has ranged from a low of $0.0806 (Nov 20, 2024) to a high of $0.2270 (May 13, 2015), with a median of $0.1287 per EA.
Are there cheaper alternatives to TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB?
TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB (NDC 53746061705) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.